Inpharma Weekly

, Volume 1621, Issue 1, pp 12–12 | Cite as

Bortezomib superior to high-dose dexamethasone for relapsed MM

Clinical study


Dexamethasone Multiple Myeloma Bortezomib Complete Response Rate Maintenance Cycle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations